Resmed Inc
(RMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 238,361 | 237,910 | 210,247 | 209,100 | 227,891 |
| Receivables | 837,275 | 779,265 | 729,740 | 692,388 | 704,909 |
| Inventories | 822,250 | 829,458 | 933,214 | 958,233 | 998,012 |
| TOTAL | $2,357,719 | $2,351,296 | $2,378,077 | $2,304,585 | $2,367,830 |
| Non-Current Assets | |||||
| PPE Net | 548,025 | 539,743 | 551,734 | 533,985 | 537,856 |
| Intangibles | 3,327,959 | 3,337,017 | 3,390,032 | 3,375,420 | 3,322,640 |
| Other Non-Current Assets | 638,691 | 586,506 | 585,245 | 526,796 | 523,382 |
| TOTAL | $4,514,675 | $4,463,266 | $4,527,011 | $4,436,201 | $4,383,878 |
| Total Assets | $6,872,394 | $6,814,562 | $6,905,088 | $6,740,786 | $6,751,708 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 237,728 | 177,445 | 202,395 | 177,048 | 150,756 |
| Accrued Expenses | 377,678 | 356,076 | 332,136 | 348,263 | 365,660 |
| TOTAL | $910,655 | $773,030 | $764,073 | $770,802 | $758,533 |
| Non-Current Liabilities | |||||
| Long Term Debt | 697,313 | 997,047 | 1,216,769 | 1,351,511 | 1,431,234 |
| Deferred Revenues | 152,554 | 150,753 | 148,897 | 146,718 | 138,072 |
| Other Non-Current Liabilities | 183,701 | 196,020 | 225,700 | 158,933 | 222,202 |
| TOTAL | $1,097,696 | $1,411,612 | $1,659,161 | $1,719,608 | $1,863,272 |
| Total Liabilities | $2,008,351 | $2,184,642 | $2,423,234 | $2,490,410 | $2,621,805 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,932 | 146,907 | 147,089 | 147,092 | 147,071 |
| Common Shares | 588 | 588 | 588 | 588 | 588 |
| Retained earnings | 4,991,647 | 4,769,963 | 4,539,963 | 4,401,841 | 4,253,016 |
| Other shareholders' equity | -251,796 | -265,569 | -208,615 | -320,404 | -272,784 |
| TOTAL | $4,864,043 | $4,629,920 | $4,481,854 | $4,250,376 | $4,129,903 |
| Total Liabilities And Equity | $6,872,394 | $6,814,562 | $6,905,088 | $6,740,786 | $6,751,708 |